作者: Andrea Pession , Riccardo Masetti , Carmelo Rizzari , Maria Caterina Putti , Fiorina Casale
DOI: 10.1182/BLOOD-2013-03-491621
关键词:
摘要: We evaluated the outcome of 482 children with acute myeloid leukemia (AML) enrolled in Associazione Italiana di Ematologia e Oncologia Pediatrica AML 2002/01 trial. Treatment was stratified according to risk group; hematopoietic stem cell transplantation (HSCT) used high-risk (HR)